Navigation Links
Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
Date:9/12/2007

ACTON, Mass., Sept. 12 /PRNewswire-FirstCall/ -- Psychemedics Corporation (Amex: PMD) was selected to participate in and co-sponsor Chief Talent Officer, an innovative new book sponsored by Accenture that addresses human resource management issues and the growing imperative for HR leaders to become chief talent officers.

Chief Talent Officer showcases chief executive officers and human resource executives who have demonstrated innovative approaches to leading and managing human capital to drive high performance. The publication also presents insights on human capital and workforce performance from key senior executives within Accenture's Human Performance practice, other industry leaders and academia. The book describes a number of proven practices for strategic leadership of the HR function that executives can implement in their organizations today.

Ultimately, organizations that are leaders in managing talent have executives at their helms that elevate human performance initiatives to a strategic corporate platform. These chief talent officers are the driving forces that transform their organizations' workforces.

Chief Talent Officer profiles a number of leaders from companies including Sara Lee Corporation, Unilever, Royal Dutch Shell, AstraZeneca and AT&T that have "cracked the code" and adopted highly effective human capital management philosophies and practices that drive competitive advantage. Through specially commissioned interviews with these leaders, the book reveals best practices for strategic leadership of the HR function and demonstrates how successful chief talent officers have brought the workforce to the forefront of the executive agendas for their organizations.

Raymond C. Kubacki, Chairman and CEO of Psychemedics, is one of the leaders profiled in the book. "We work with HR executives every day of the week on how to reduce risk, including making sure that human assets don't become a liability," he states in the book. "We have a very large number of clients who are consistently addressing employee risk factors and understand how important those decisions are in creating a top-notch workforce and a positive workplace environment."

"Chief Talent Officer is very innovative," said Kubacki. "As HR executives undertake the journey to chief talent officers, the top human resource executive needs to become the chief talent officer and many companies are already in that mode to drive performance. Full implementation of this successful platform, however, is also dependent upon the CEO recognizing the significance of this CTO position and clearly establishing its importance within the whole organization."

The book will be distributed to CEO's and top HR professionals within Accenture's client organizations in the US and internationally. Total distribution will be 20,000.

About Psychemedics

Psychemedics is the world's largest provider of hair testing for drugs of abuse with thousands of corporations relying on the patented Psychemedics drug testing services. Psychemedics' clients include over 10% of the Fortune 500, some of the largest police departments in America and Federal Reserve Banks.

The Psychemedics web site is http://www.drugtestwithhair.com

Contact:

Raymond C. Kubacki

Chairman and CEO, Psychemedics Corporation

978-206-8220

Cautionary Statement for purposes of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995: From time to time, information provided by Psychemedics may contain forward-looking information that involves risks and uncertainties. In particular, statements contained in this release that are not historical facts (including but not limited to statements concerning growth, earnings, profit margins, earnings per share, revenues, dividends, future business, new accounts, customer base, market share, test volume and sales and marketing strategies) may be "forward looking" statements. Actual results may differ from those stated in any forward-looking statements. Factors that may cause such differences include but are not limited to risks associated with the expansion of the Company's sales and marketing network, development of markets for new products and services offered, the economic health of principal customers of the Company, government regulation, including but not limited to FDA regulations, competition and general economic conditions and other factors disclosed in the Company's filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Psychemedics Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
2. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
3. Rat joins list of cloned animals
4. Richard Gere Joins Indian Stars For Fight Against AIDS
5. Enbrel Joins with Methotrexate to Cure Rheumatoid Arthritis
6. Anoushka Joins Hands With WFP to Feed the Poor
7. India Joins Hands With Global Body for Vaccine Research
8. Another Statewide Organization Joins the Fight Against Assisted Suicide
9. Two-year-old Joins Mensa, Becomes Its Youngest Ever Genius
10. Innovative device aids in advanced heart failure
11. Innovative footwear may prevent fall in elderly
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... American Veterinarian™, the ... on veterinary medicine, announces the launch of Veterinarian’s Money Digest™, a business and ... April edition of American Veterinarian™. , “We look forward to launching ...
(Date:3/27/2017)... ... March 27, 2017 , ... EpiGentek , a Farmingdale, ... recent RNA methylation “gold rush” with their established portfolio of optimized assay kits ... N6-methyladenosine, or m6A , RNA methylation has received a new burst in ...
(Date:3/27/2017)... ... 27, 2017 , ... According to the American Cancer Society , the ... than 95%. Once the cancer spreads to other organs, bones, or lymph nodes, however, ... to avoid this latter group, tune in to Lifestyle Magazine on April ...
(Date:3/27/2017)... ... March 27, 2017 , ... ?Grow Healthy ... resolve the pending litigation between itself and 1800 Vending DBA Healthy You Vending. ... “I am thrilled to announce that we have now reached a settlement agreement ...
(Date:3/27/2017)... ... March 27, 2017 , ... Harris Communications, Inc., a leading ... bringing its latest products to the Deaf Seniors of America Conference, April 4-7 at ... to meet with knowledgeable ASL friendly staff from Harris Communications and to try out ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Medtec Europe will once ... 600 exhibitors from 70 countries the opportunity to ... will advance the medical technology industry. Taking place ... Stuttgart, Stuttgart, Germany , Medtec ... the key trends and insights across the entire ...
(Date:3/27/2017)... March 27, 2017  Sophiris Bio Inc. (NASDAQ: ... a clinical late-stage biopharmaceutical company developing topsalysin (PRX302) ... today reported fourth quarter and full year 2016 ... Key Corporate Highlights: Advanced ... Cancer. During 2016, the Company reported successful results ...
(Date:3/27/2017)... 2017 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus MD" ... MD is pleased to announce it has received conditional ... the TSX Venture Exchange.  Receiving the ... of significant achievements for Invictus-MD. Some of which include: ... AB Laboratories Inc. ("AB Labs"), a Licensed Producer under ...
Breaking Medicine Technology: